Article
NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
Biological chemistry - 1 Oct 2002
Prösch Susanna, Wuttke Regine, Krüger Detlev H, Volk Hans-Dieter
Abstract excerpt
From clinical studies the proinflammatory cytokine TNFalpha was proposed to play a key role in human cytomegalovirus (HCMV) reactivation from latency. In vitro experiments confirmed that TNFalpha stimulates the activity of the HCMV IE1/2 enhancer/promoter, which controls immediate early protein IE1 and IE2 gene expression via activation of the transcription factor NF-kappaB and its binding to putative binding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
